Tel. 050 992687 , 050 992684

it
Logo

Per saperne di più

Attività assistenziale

Attività di Ricerca

Pubblicazioni

Riportiamo le nostre pubblicazioni

  1. Tavoni A, Mosca M, Ferri C, Moriconi L, La Civita L, Bombardini F, Bombardieri S. Guidelines for the management of essential mixed cryoglobulinemia. Clin. Exp. Rheumatol. 1995; 13 (suppl. 13): S- 191-195.
  2. Vitali C, Bombardieri S, Moutsopoulos H, Coll J, Gerli R, Hatron P, Kater L, Konttinen Y, Manthorpe R, Meyer O, Mosca M, Ostuni P et al. (The European Study Group on Diagnostic Criteria for Sjögren Syndrome). Assessment of the European classification criteria for Sjögren syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann. Rheum. Dis. 1996; 55; 116-121.
  3. Mosca M, Pasquariello A, Tavoni A, Moriconi L, Moneta I, Bencivelli W, Bombardieri S. Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus. Lupus 1997; 6; 371-378.
  4. Boggi U, Mosca M, Giulianotti PC, Bombardieri S, Mosca F. Surviving catastrophic gastrointestinal involvement due to Churg-Strauss syndrome: report of a case. Hepato- gastroenterol.1997: 44; 1169-1171
  5. Bombardieri S, Neri R, Mosca M. Cytotoxic drugs in systemic lupus erythematosus. Rheumatology in Europe 1998; 3: 116-118.
  6. Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least one year. Lupus, 1998; 2: 95- 100.
  7. Berrettini S, Ferri C, Ravecca F, La Civita L, Bruschini L, Riente L, Mosca M, Sellari- Franceschini S. Progressive sensorineural hearing impairement in systemic vasculitides. Sem. Arthr. Rheum. 1998; 5: 301- 318.
  8. Vitali C, Bencivelli W, Mosca M, Carrai P, Sereni M, Bombardieri S. Development of a computerized clinical chart to compute different disease activity indices for systemic lupus erythematosus. J. Rheumatol. 1999; 26 (2): 498-501.
  9. Neri R, Mosca M, Bernacchi E, Bombardieri S. A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. Lupus 1999; 8 (3): 240-243.
  10. AJ Swaak, HG van Den Brink, RJ Smeenk, K Manger, JR Kalden, S Tosi, A Marchesoni, Z Domljan, B Rozman, D Logar, G Pokorny, L Kovacs, A Kovacs, PG Vlachoyannopoulos, HM Moutsopoulos, H Chawalinska-Sadowska, B Dratwianka, E Kiss, N Cike, A Branimir, M Schneider, R Fischer, S Bombardieri, M Mosca, W Graninger et al. Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 1999; 38 (10): 953-958.
  11. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999; 17 (5): 615-620.
  12. Neri R, Mosca M, Bombardieri S. Anticorpi anti-ENA. Laborama 1999; 4: 12-16.
  13. Curcio M, Mosca M, Lapi S, Filipponi F, Mosca F, Italia S, Rizzo G. Usefulness of direct sequencing in the detection of microchimerism in liver transplant recipients. Transplantation 2000; 69: 191.
  14. Mosca M, Bencivelli W, Vitali C, Carrai P, Neri R, Bombardieri S. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 2000; 9: 445-450.
  15. Mosca M, Neri R, Pasero G, Bombardieri S. Treatment of the idiopathic inflammatory myopathies: A retrospective analysis of 63 Caucasian patients longitudinally followed at a single center. Clin Exp Rheumatol 2000; 18, 451-456.
  16. Danesi R, Mosca M, Boggi U, Mosca F, Del Tacca M. Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy. Molecular Medicine Today 2000; 6: 475-482.
  17. Mosca M, Neri R, Riannessi S, Pasquariello A, Morioni L, Puccini R, Bencivelli W, Bombardieri S. Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis. Lupus, 2001; 10: 253-257
  18. Mosca M, Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Treatment of systemic lupus erythematosus. Int Immunopharmacol 2001; 1: 1065-1075
  19. AJ Swaak, HG van den Brink, RJT Smeenk, K Manger, JR Kalden, S tosi, Z Domjlian, B Rozman, D Logar, G Pokorny, L Kovacs, PG Vlachoyiannopoulos, HM Moutsopoulos, H Chwalinska-Sadowska, E Kiss, N Cikes, B Anic, M Schneider, R Fischer, S Bombardieri, M Mosca, W Graninger, JS Smolen. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation. Lupus 2001; 10: 51-38.
  20. AJ Swaak, HG van den Brink, RJT Smeenk, K Manger, JR Kalden, S tosi, A Marchesoni, Z Domjlian, B Rozman, D Logar, G Pokorny, L Kovacs, A Kovacs, PG Vlachoyiannopoulos, HM Moutsopoulos, H Chwalinska-Sadowska, B Dratwianka, E Kiss, N Cikes, B Anic, M Schneider, R Fischer, S Bombardieri, M Mosca, W Graninger, JS Smolen. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR standing committee on international clinical studies including therapeutic trials (ESCISIT) Rheumatology 2001; 40: 89-94.
  21. Mosca M, Bombardieri S. Undifferentiated connective tissue diseases: a new frontier in rheumatology. Curr Rheumatol Rep. 2001; 3: 259- 260.
  22. S Crotta, A Stilla, A Waak, A D'Andrea, S Nuti, U D'Oro, M Mosca, F Filipponi, RM Brunetto, F Bonino, S Abrignani, NM Valiante. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med. 2002;195: 35- 41.
  23. Mosca M, Bencivelli W, Neri R, Pasquariello A, Batini V, Puccini R, Tavoni A, Bombardieri S. Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int. 2002; 61: 1502- 1509.
  24. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M; Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002; 46: 1019-1027.
  25. Mosca M, Neri R, Bencivelli W, Tavoni A, Bombardieri S. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow up of 5 years. J Rheumatol. 2002; 29: 2345- 2349
  26. Neri R, Mosca M, Grazzini T, Tavoni A, Pasero G, Bombardieri S. Long term functional outcome of idiopathic inflammatory myopathies. Reumatismo. 2001; 53: 40-45
  27. Mosca M, R Neri R, Strigini F, Carmignani A, Totti D, Tavoni A, Bombardieri S. Pregnancy outcome in patients with undifferentiated connective tissue disease: a preliminary study on 25 pregnancies. Lupus. 2002; 11: 304-307.
  28. Mosca M, Curcio M, Lapi S, Valentini G, D'Angelo S, Rizzo G, S Bombardieri. Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis. 2003; 62 (7): 651-654.
  29. Tolusso M, Fabris M, Gremese E, Mosca M, Rovere-Querini, Ferraccioli GF. Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association. Ann Rheum Dis. 2003; 62: 781-782.
  30. Galli-Stampino L, Pasqualini A, Pozzato G, Bonino F, Filipponi F, Mosca M, Masciopinto F, Abrignani S, Uematsu Y. Molecular analysis of VHI B lymphocytes in hepatitis C patients. Dig Liv Dis 2003; 35: 788-794
  31. Mosca M, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases in the 2004. Clin Exp Rheumatol 2004; 22: S 14-18
  32. Mosca M, Baldini C, Bombardieri S. The value of outcome measures in autoimmune rheumatic diseases. Autoimmun Rev. 2004; 3: S56-57.
  33. Di Munno O, Mazzantini M, Delle Sedie A, Mosca M, Bombardieri S. Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus. 2004;13: 724-730
  34. Mosca M, Strigini, A, D'ascanio A, Genazzani AR, Bombardieri S. Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum. 2005; 53:119- 121.
  35. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol. 2005; 32: 213-215. IP 3.551
  36. Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005;19: 685-708.
  37. Hengstman GJ, Vree Egberts WT, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, Mosca M, Vencovsky J, van Venrooij WJ, van Engelen BG. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis. 2006;65: 242-5.
  38. Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M. Lupus erythematosus and the skin. Clin Exp Rheumatol. 2006;24(1 Suppl 40):S26-35.
  39. Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupuserythematosus. J Rheumatol. 2006; 33: 695-7.
  40. Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis. 2006; 65: 1635-8.
  41. Tani C, Mosca M, d'Ascanio A, Versari D, Virdis A, Ghiadoni L, Taddei S, Salvetti A, Bombardieri S. Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. Reumatismo. 2006; 58: 212-8.
  42. Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol. 2006; 24 (Suppl 43):S099-104.
  43. Mosca M, Tani C, Neri C, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev. 2006; 6: 1-4
  44. Neri R, Mosca M, Stampacchia G, Vesprini E, Tavoni A, d'Ascanio A, Bombardieri S. Functional and isokinetic assessment of muscle strength in patients with idiopathic inflammatory myopathies. Autoimmunity. 2006; 39: 255-9.
  45. Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol. 2006; 1: 925-32.
  46. Mosca M, Strigini F, Doria A, Pratesi F, Tani C, Iaccarino L, Chimenti D, Carmignani A, Cecchi M, Zampieri S, Ghirardello A, Migliorini P, Bombardieri S. Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2007 May-Jun;25(3):449-52.
  47. Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M, Olesinska M,Pokorny G, Rozman B, Schneider M, Vlachoyiannopoulos PG, Swaak A. Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual. Lupus. 2007;16(5):309-17.
  48. Mosca M, Baldini C, Bombardieri S. LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus. Expert Opin Pharmacother. 2007 Apr;8(6):873-9.
  49. Carmignani A, Mosca M, Strigini FA, Tani C, Cecchi M, Morini P, Genazzani AR. P26.08: Bilateral hemorrhagic fetal ovarian cyst: a case report. Ultrasound Obstet Gynecol. 2007 21; 30: 548-549
  50. Mosca M, Bombardieri S. Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE). Clin Exp Rheumatol. 2007; 6 Suppl 47: 107- 113
  51. Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Practice & Research Clinical Rheumatology 2007; 21(6):1011-23.
  52. Mosca M, Tani C, Bombardieri S. A case of undifferentiated connective tissue disease: is it a distinct clinical entity? Nature Clinical Practice Rheumatology 2008; 4: 328- 332
  53. Mosca M, Tani C, Bombardieri S. Defining undifferentiated connective tissue diseases: a challenge for rheumatologists. Lupus 2008; 17: 278- 280
  54. Mosca M, Tani C, Neri C, Della Rossa Am Baldini C, Talarico R, Carli L, Bombardieri S. Evoluzione verso connettiviti definite in una popolazione di pazienti affetti da “Early Undifferentiated Connective Tissue Disease”. Reumatismo, 2008; 60: 35-40
  55. Mosca M, Carli L, d'Ascanio A, Tani C, Talarico R, Baldini C, Bazzichi L, Tavoni A, Migliorini P, Bombardieri S. Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews. Clin Rheumatol. 2008; 27: 1045-1048.
  56. Ghiadoni L, Mosca M, Tani C, Virdis A, Taddei S, Bombardieri S. Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. Clinical and Experimental Rheumatology 2008; 26: 680-7.
  57. Mosca M, Giuliano T, Curcio M, Doveri M, De Feo F, Tani C, Bazzichi L, Bombardieri S. Comparison of real time PCR and nested PCR for the detection of Y chromosome sequences in the PBMN of patients with systemic sclerosis. Ann Rheum Dis. 2009; 68:155-6
  58. Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, Zeher MM, Tincani A, Kontopoulou-Griva I, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Piette JC, Espinosa G, Bucciarelli S, Pisoni CN, Bertolaccini ML, Boffa MC, Hughes GR. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1,000 patients. Ann Rheum Dis. 2008
  59. Mosca M, Virdis A, Tani C, Ghiadoni L, Versari D, Duranti E, d'Ascanio A, Salvetti A, Taddei S, Bombardieri S. Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis. 2009; 203: 185- 191
  60. Rossi M, Mosca M, Tani C, Franzoni F, Santoro G, Bombardieri S. Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus. Clin Rheumatol. 2008; 27: 1485-8.
  61. Kuhn A, Kuehn E, Meuth AM, Haust M, Nyberg F, Werth V, Ruzicka T, Schmitt V, Bonsmann G; EUSCLE Study Group. Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev. 2009; 8: 702-12.
  62. Tani C, Mosca M, Colucci R, Gori G, d'Ascanio A, Ghisu N, Fornai M, Di Paolo A, Blandizzi C, Del Tacca M, Bombardieri S. Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases. Clin Exp Rheumatol. 2009;27:321-4.
  63. Baldini C, Della Rossa A, Grossi S, Catarsi E, Talarico R, d'Ascanio A, Mosca M, Neri R, Tavoni A, Bombardieri S. [Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre]. Reumatismo. 2009;61:118-24.
  64. Mosca M, Giuliano T, Cuomo G, Doveri M, Tani C, Curcio M, Abignano G, De Feo F, Bazzichi L, Della Rossa A, Valentini G, Bombardieri S. Cell-free DNA in the plasma of patients with systemic sclerosis. Clin Rheumatol. 2009;28:1437-40.
  65. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, van Vollenhoven RF, Ward MM, Werth VP, Carmona L. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010;69:1269-74.
  66. Antonelli A, Mosca M, Fallahi P, Neri R, Ferrari SM, D'Ascanio A, Ghiri E, Carli L, Miccoli P, Bombardieri S. Thyroid cancer in systemic lupus erythematosus: a case-control study. J Clin Endocrinol Metab. 2010; 95: 314-318.
  67. Antonelli A, Fallahi P, Mosca M, Ferrari SM, Ruffilli I, Corti A, Panicucci E, Neri R, Bombardieri S. Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism. 2010; 59: 896-900.
  68. Nossent J, Kiss E, Rozman B, Pokorny G, Vlachoyiannopoulos P, Olesinska M, Marchesoni A, Mosca M, Påi S, Manger K, Schneider M, Nielsen H, van Vollenhoven, R, Swaak T. Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus. Lupus. 2010; 19: 949-56.
  69. Mosca M, Bombardieri S, Carmona L. Assessment of multiple organ systems in systemic lupus erythematous. What will the new guidelines mean? Int J Clin Rheumatol 2010; 5: 291-297
  70. Mosca M, Tani C, Talarico R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. Autoimmun Rev. 2011; 10: 256-8.
  71. Giovacchini G, Mosca M, Manca G, Della Porta M, Neri C, Bombardieri S, Ciarmiello A, Strauss HW, Mariani G, Volterrani D. Cerebral blood flow in depressed patients with systemic lupus erythematosus. J Rheumatol. 2010; 37:1844-51
  72. Tani C, Mosca M, d'Ascanio A, Neri R, Tavoni A, Carli L, Bombardieri S. [Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide]. Reumatismo. 2010; 62: 215-220.
  73. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Schneider M, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, Ward MM, Werth VP, Carmona L. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev. 2011; 10: 383-8
  74. Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford). 2011; 50: 1684-9.
  75. Tani C, Carli L, Mosca M, Baldini C, Consensi A, Doveri M, Talarico R, Bombardieri S. [Adherence to cervical cancer screening in an Italian SLE cohort]. Reumatismo. 2011; 63: 11-17.
  76. Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, Conti F, D'Cruz D, Doria A, De La Fuente D, Galeazzi M, Houssiau F, Huizinga TW, Khamashta MA, Ines L, Duarte C, Couto M, Meroni P, Montecucco C, Norkuviene E, Riemekasten G, Rios V, Schneider M, Shoenfeld Y, Steup-Beekman GM, Szmyrka-Kaczmarek M, Tani C, Tincani A, Tzioufas AG, Voll R, Bencivelli W, Salaffi F, Bombardieri S. The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice. Lupus. 2011; 20:485-92.
  77. Ble A, Mosca M, Di Loreto G, Guglielmotti A, Biondi G, Bombardieri S, Remuzzi G, Ruggenenti P. Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis. Am J Nephrol. 2011;34:367-372.
  78. Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M. "To Be or Not To Be," Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity. Semin Arthritis Rheum. 2011 Sep 27.
  79. Taraborelli M, Ramoni V, Brucato A, Airò P, Bajocchi G, Bellisai F, Biasi D,Blagojevic J, Canti V, Caporali R, Caramaschi P, Chiarolanza I, Codullo V, Cozzi F, Cuomo G, Cutolo M, De Santis M, De Vita S, Di Poi E, Doria A, Faggioli P,Favaro M, Ferraccioli G, Ferri C, Foti R, Gerosa A, Gerosa M, Giacuzzo S, Giani L, Giuggioli D, Imazio M, Iudici M, Iuliano A, Leonardi R, Limonta M, Lojacono A,Lubatti C, Cerinic MM, Mazzone A, Meroni M, Meroni PL, Mosca M, Motta M, Muscarà M, Nava S, Padovan M, Pagani G, Paolazzi G, Peccatori S, Ravagnani V, Riccieri V,Rosato E, Rovere-Querini P, Salsano F, Santaniello A, Scorza R, Tani C, Valentini G, Valesini G, Vanoli M, Vigone B, Zeni S, Tincani A; on behalf of the IMPRESS investigators.. Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study. Arthritis Rheum. 2011 Dec 28. doi: 10.1002/art.34350.
  80. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, Conti F, De Vita S, Doria A, Farina I, Ferraccioli G, Gremese E, Mansutti E, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto P, Taglietti M, Trotta F, Valesini G, Zen M, Mathieu A; on behalf of the Italian Society of Rheumatology. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford). 2012;51:157-168.
  81. Mosca M, Tani C, Carli L, Bombardieri S. Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol. 2011;29(5 Suppl 68):S126-9
  82. Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmun Rev. 2011 Oct 25. [Epub ahead of print]